SI
SI
discoversearch

Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3540 181 0
Emcee:  dalroi Type:  Moderated
this forum is for firesale alerts

stock need to drop more then 15% in 1 day
AND
1/ dont spam on this board
2/ if in the next days it doesnt drop 15% discuss it somewhere else

reversals are ok as long as the post is made around the 15% droppoint

try to give a reason why it did it and use the ticker in headline

mean reason for this board IS ALLERTING so one knows there is something going on
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3540VTVT has a couple of programs in T2D that are nothing special, IMO. DewDiligence_on_SI-April 9
3539Speaking of not seeing effective AD treatments in my lifetime . . . VTVtuck-April 9
3538reading that brings back very sad memories.semi_infinite -April 9
3537Here is the link to the ACAD response to CNN, with some facts. Gottlieb also caBiotech Jim1April 9
3536My granddad had Parkinson's psychosis, and had to be separated from his wifetuck-April 9
3535My mother had LBD and struggled with it for years before succumbing in her late semi_infinite -April 9
3534Acadia (ACAD) off ~20% on negative article about Nuplazid, suggesting label expatuck-April 9
3533MNLO down more than 50% on trial failureJamesK-April 9
3532MannKind (MNKD) off 21% on stock offering. Now well below $2. Not a buying op,tuck-April 6
3531Incyte (INCY) of 20% from already depressed prices on failure of ECHO-301, a P3 tuck-April 6
3530They are "warrants", without obligation. Still, positive for GLMD.Miljenko Zuanic-April 4
3529Astonishingly good terms for GLMD. Warrants very far out-of-the-money (3x pre-exDewDiligence_on_SI-April 3
3528OT: finance.yahoo.com BVF see value in Aramchol!Miljenko Zuanic-April 3
3527RIGL down 17% on fostamatinib fail in IgA nephropathy failmopgcw-April 3
3526Edge Therapeutics (EDGE) off 88% as I type on P3 whiff in subarachnoid hemorrhatuck1March 28
3525Dose response curve does not fit, what dose will they used going forward????Miljenko Zuanic-March 19
3524CDTX - 22% down. News release this morning that initially looked good sending thSteve Lokness-March 19
3523Believing that he does not have data already? I am frustrated that there is delaMiljenko Zuanic-March 13
3522What would be the point of promising data that they have no intention of deliverDewDiligence_on_SI-March 13
3521And you believe him (GLMD CEO)? How many weeks one needs to do ALT/AST liver leMiljenko Zuanic1March 13
3520We may be in a better position to speculate on why ARRIVE failed when we see theDewDiligence_on_SI-March 13
3519RE GLMD: Aramchol P2b (300, 600 mg, placebo) data from ARREST in June, MRI/MRS Miljenko Zuanic1March 13
3518Thanks for sharing. Always instructive to see a seasoned Biotech investor takinFiloF1March 5
3517Re: Dermira's lebrikizumab. Well, it's still in P2 for dose optimizatiotuck1March 5
3516I do not remember the name of the analyst that wrote a note on this. He was tryBiotech Jim-March 5
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.